Absorbable iron-based instrument
An iron-based and device technology, applied in the field of absorbable iron-based devices, can solve problems such as corrosion of iron-based devices and affect the structural integrity and mechanical properties of iron-based devices, to accelerate corrosion, reduce the possibility of adverse reactions, and avoid cell damage. toxic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0074] The absorbable iron-based stent provided in Example 1 is composed of a plurality of stent rods. See figure 1 , each stent rod includes an iron-based substrate 11 , a zinc-containing protective body 12 completely covering the iron-based substrate 11 , and a degradable polyester coating 13 completely covering the zinc-containing protective body 12 . The iron-based substrate 11 is made of an iron-based alloy with a carbon content of 1.19%. The zinc-containing protective body 12 is a single zinc coating. The degradable polyester coating 13 is poly-racemic lactic acid with a mass fraction of low molecular weight fractions below 10,000 of 2% and a mass fraction of residual monomers of 1.6%.
[0075] The manufacturing process of the absorbable iron-based stent provided in Example 1 is as follows:
[0076] On the surface of the iron-based stent with an original radial support force of 145kPa and a mass of 4.5mg, the vacuum evaporation method is used to uniformly plate zinc a...
Embodiment 2
[0081] On the surface of the iron-based stent with an original radial support force of 145kPa and a mass of 4.5mg, the vacuum evaporation method is used to uniformly plate zinc as a zinc-containing protective body, so that the zinc element completely covers the surface of the iron-based stent, and the mass of the zinc element The mass ratio to the iron-based support is 1:200 to obtain a galvanized iron-based support. The polyracemic lactic acid is separated and purified by GPC method, and the mass fraction of the low molecular weight part with a molecular weight of less than 10,000 is 2%, and the mass fraction of the residual monomer is 1.6%. The obtained polyracemic lactic acid was dissolved in ethyl acetate to obtain a coating solution. Spray the coating solution onto the surface of the galvanized iron-based stent, and make the ratio of the mass of polyracemic lactic acid to the mass of the iron-based stent be 1:10, dry to remove ethyl acetate, crimp on the crimping device a...
Embodiment 3
[0084] On the surface of the iron-based stent with an original radial support force of 145kPa and a mass of 4.5mg, the vacuum evaporation method is used to uniformly plate zinc as a zinc-containing protective body, so that the zinc element completely covers the surface of the iron-based stent, and the mass of the zinc element The mass ratio to the iron-based support is 1:20 to obtain a galvanized iron-based support. The polyracemic lactic acid is separated and purified by GPC method, and the mass fraction of the low molecular weight part with a molecular weight of less than 10,000 is 2%, and the mass fraction of the residual monomer is 1.6%. The obtained polyracemic lactic acid was dissolved in ethyl acetate to obtain a coating solution. Spray the coating solution onto the surface of the galvanized iron-based bracket, and make the ratio of the mass of polylactic acid to the mass of the iron-based bracket 1:10, dry to remove ethyl acetate, press on the crimping equipment and us...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com